Publishers Alliance Archives - Cancer Therapy Advisor

Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients

By

Syed Hasan Raza Jafri, Carlos Previgliano, Keerti Khandelwal, Runhua Shi

November 26, 2015

[Clinical Medicine Insights: Oncology] Cancer cachexia affects many advanced non-small-cell lung cancer (NSCLC) patients.

Breast Cancer

Validation study of the modified injection technique for internal mammary sentinel lymph node biopsy in breast cancer

By

Bin-Bin Cong, Xiao-Shan Cao, Peng-Fei Qiu, Yan-Bing Liu, Tong Zhao, Peng Chen, Chun-Jian Wang, Zhao-Peng Zhang, Xiao Sun, Yong-Sheng Wang

October 9, 2015

[OncoTargets and Therapy] According to the hypothesis of internal mammary sentinel lymph node, lymphatic drainage pattern, a modified radiotracer injection technique was established.

Pancreatic Cancer

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease

By

Célia Turco, Marine Jary, Stefano Kim, Mélanie Moltenis, Bruno Degano, Philippe Manzoni, Thierry Nguyen, Bruno Genet, Marie-Blanche Valnet Rabier, Bruno Heyd, Christophe Borg

September 30, 2015

[Clinical Medicine Insights: Oncology] Although myelosuppression is the most adverse event of this therapy, gemcitabine might induce severe pulmonary toxicities.

Blood and Lymphatic Cancer: Targets and Therapy

Chronic Myeloid Leukemia

Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose

By

Joanna Waclaw, Tomasz Sacha, Tomasz Stoklosa

September 25, 2015

[Blood and Lymphatic Cancer Targets and Therapy] Imatinib was the first tyrosine kinase inhibitor (TKI), successfully used in a clinical setting.

Lymphoma

Non-Hodgkin Lymphoma of the Stomach in a Patient Treated With Natalizumab

By

Jennie Y. Law, Dong W. Kim, Ariel Strugis, Harris V. Naina

August 11, 2015

[Clinical Medicine Insights: Oncology] Given the absence of association between multiple sclerosis, diffuse large B-cell lymphoma, causal association with natalizumab cannot be excluded.

Hematologic Cancers

Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology

By

Mohammad Hussaini, MD

July 31, 2015

[Cancer Control] Molecular testing is entrenched in the workup and management of hematological malignancies.

Lung Cancer

BRAF mutations in non-small cell lung cancer

By

Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper

June 15, 2015

[Translational Lung Cancer Research] This research investigates the prevalence and clinicopathological features of BRAF mutations in non-small cell lung cancer (NSCLC) cases submitted for routine mutation testing.

General Oncology

CD151—A Striking Marker for Cancer Therapy

By

Seema Kumari, Gayatri Devi V., Anil Badana, Venkata Ramesh Dasari, and Rama Rao Malla

May 21, 2015

[Biomarkers in Cancer] Cluster of differentiation 151 (CD151) functions at various stages of cancer, including metastatic cascade and primary tumor growth, reinforcing the importance of CD151 as a target in oncology.

Breast Cancer

Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis

By

Bethan Frugtniet, Wen G. Jiang, Tracey A. Martin

May 15, 2015

[Breast Cancer: Targets and Therapy] This review focuses on the role of the WASP/WAVE family in breast cancer cell invasion and migration.

Palliative Care

Threading the cloak: palliative care education for care providers of adolescents, young adults with cancer

By

Lori Wiener, Meaghann Shaw Weaver, Cynthia J. Bell, Ursula M. Sansom-Daly

May 7, 2015

[Clinical Oncology in Adolescents and Young Adults] Integration of palliative care at the time of diagnosis enables a supportive partnership with the medical team.

Diagnosis & Disease Information